Showing 841 - 860 results of 55,675 for search '(( 5 ((ng decrease) OR (we decrease)) ) OR ( 100 ((mean decrease) OR (a decrease)) ))', query time: 1.08s Refine Results
  1. 841

    S1 Data - by Francois Kiemde (5369657)

    Published 2024
    “…Venous blood was collected at scheduled visit: Visit 1 (V1; 16–20 weeks of amenorrhea), Visit 2 (V2; 28 ±1 weeks of pregnancy), Visit 3 (V3; 32 ±1 weeks of pregnancy), Visit4 (V4; delivery) and Visit5 (V5; 6–7 weeks after delivery). …”
  2. 842

    Characteristic of study population. by Francois Kiemde (5369657)

    Published 2024
    “…Venous blood was collected at scheduled visit: Visit 1 (V1; 16–20 weeks of amenorrhea), Visit 2 (V2; 28 ±1 weeks of pregnancy), Visit 3 (V3; 32 ±1 weeks of pregnancy), Visit4 (V4; delivery) and Visit5 (V5; 6–7 weeks after delivery). …”
  3. 843
  4. 844
  5. 845
  6. 846
  7. 847
  8. 848
  9. 849
  10. 850
  11. 851
  12. 852
  13. 853
  14. 854
  15. 855
  16. 856
  17. 857

    IFN-λ1 decreases miR-122 transcription through down regulation of HNF4α. by Fatma Aboulnasr (736868)

    Published 2015
    “…<p><b>(A and B)</b> S3-GFP and R4-GFP cells were treated either IFN-α (1000 I.U/mL) or IFN-λ (100ng/mL). …”
  18. 858

    Inhibition of HDAC6 activity decreased the levels of EGFR and increased acetyl-α-tubulin in renal epithelial cells. by Wei Liu (20030)

    Published 2013
    “…(C) and (D) Western blotting analysis of the expression of EGFR and acetyl-α-tubulin in <i>Pkd1</i> wild-type (WT) MEK cells (C) and <i>Pkd1<sup>null/null</sup></i> (Null) MEK cells (D) treated with or without TSA (100 ng/ml). TSA treatment decreased the levels of EGFR and increased the acetyl-α-tubulin in <i>Pkd1<sup>null/null</sup></i> (Null) MEK cells. …”
  19. 859
  20. 860

    A Peptide Mimetic of 5-Acetylneuraminic Acid-Galactose Binds with High Avidity to Siglecs and NKG2D by Laura L. Eggink (760403)

    Published 2015
    “…Using plant lectins as analogs of lectin-type cell-surface receptors, a tetravalent form of a peptide with the sequence NPSHPLSG, designated svH1C, bound with high avidity to lectins specific for glycans with terminal 5-acetylneuraminic acid (Neu5Ac)-galactose (Gal)/N-acetylgalactosamine (GalNAc) sequences. …”